May 2026
đź“Ł VC round data is live. Check it out!
Largest HealthTech Public Companies in Denmark
Benchmark revenue and EBITDA valuation multiples for public comps like
Ambu, GN Store Nord, ChemoMetec, Curasight and Bioporto.
 | Ambu AS provides medical technology solutions. The company’s business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World. | $11 | -32% | $3B | $3B | 3.0x | 15.5x | ||
| GN Store Nord is a Danish company offering medical and audio solutions. The group comprises three businesses: Hearing (about 40% of sales), Enterprise (40%), and Gaming (20%). GN Hearing offers hearing aids and competes globally with Sonova, Demant, Starkey, and WS Audiology (formerly Sivantos and Widex). GN Enterprise provides headsets and speakerphones to the enterprise market, including contact centers and offices. GN recently acquired SteelSeries, a provider of gaming accessories such as headsets and keyboards, thereby forming the Gaming division. The company has positioned itself as a major player in the Unified Communication-enabled headsets market. The firm's premium brands are Resound in hearing, Jabra in headsets, and SteelSeries in gaming. | $15 | -1% | $2B | $4B | 1.3x | 8.6x | ||
| ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment. | $52 | -36% | $910M | $868M | 11.1x | 21.3x | ||
| Curasight AS is a clinical-stage biotech company committed to improving both the diagnosis and the treatment of certain types of cancer. The company is focused on generating data with both uTRACE and uTREAT in cancers, including prostate cancer and glioblastoma (brain cancer), neuroendocrine tumors (NET), head and neck cancer, non small cell lung cancer (NSCLC), and pancreatic cancer. | $2 | +312% | $114M | $109M | — | (12.8x) | ||
| Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. | $0 | -11% | $96M | $88M | 14.1x | (6.8x) | ||
| FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery. | $4 | -1% | $73M | $65M | — | (10.4x) | ||
| ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making. | $2 | +35% | $16M | $13M | 9.3x | (8.0x) | ||
| Scandinavian Medical Solutions AS is a provider of Medical Imaging equipment. The company specializes in the acquisition, quality check, and resale of high-quality pre-owned medical imaging systems. The company supplies value-added resellers and distributors in various countries with MRI, CT, PET/CT, and other diagnostic scanners. It operates the business through three business areas, Equipment Solutions, Parts Solutions and Rental Solutions. Equipment Solutions is the company's main source of revenue, which focuses on sourcing, inspecting, and selling imaging systems such as MRI, CT, PET/CT, Cath-Lab, and Mammography units. | $0 | -41% | $12M | $22M | 0.6x | 12.9x | ||
| Monsenso AS is a mobile mental health company. It technology company offering a digital health solution used for decentralized trials, remote patient monitoring, and treatment support. Its mHealth solution for mental health consists of three components, namely A smartphone app for individuals, A web portal for clinicians & users, and A smartphone app for careers. | $0 | -5% | $3M | $3M | 2.1x | (6.2x) | ||
| Brain+ AS is a digital therapeutics company. It is focused on developing and commercializing solutions for dementia care and with a primary focus on Cognitive Stimulation Therapy (CST). The company has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI). The company is developing Ayla, a scalable dementia care platform that provides software-based therapy and care solutions designed to support individuals with dementia. | $0 | -86% | $461K | ($219K) | — | — | ||
| Median | $2 | -8% | $84M | $77M | 3.0x | (6.2x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.